Corrected sinus node recovery time (CSNRT) and atrioventricular node effective refractory period are longer in nonsedated adults than in sedated children at cardiac catheterization. We attempted to ascertain the relative contributions of age and catheterization sedation on these differences by studying adult beagles and beagle puppies previously instrumented with atrial pacing wires. We found that CSNRT was similar in adults and puppies prior to drug administration. CSNRT shortened significantly after meperidine, promethazine, and chlorpromazine (DPT) administration in both adult dogs and puppies. Atrioventricular node effective refractory period (AVERP) was shorter in puppies than adults prior to DPT, and did not shorten in either group after DPT. These findings suggest that the difference between CSNRTs in children and adults can be at least partly explained by the sedation used in children. This is an important consideration when premedicating children for electrophysiologic studies, particularly in children with suspected sinus node dysfunction.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.